Chennai Meenakshi Multispecialit (BSE: 523489) is a Chennai, Tamil Nadu-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹28 Cr, it ranks #4,343 by market cap among the 6,137 Indian listed companies on FinBizNet, and #36 of 42 in Hospitals and Healthcare Centers. At ₹36.40 (as of 25 Oct 2026), the share price is 36.7% below its 52-week high of ₹57.48 and 15.5% above its 52-week low of ₹31.51. The share price is down 21.3% over one year and down 2.4% over three months.
| Current Price | ₹36.40 |
|---|---|
| Market Cap | ₹28 Cr |
| BSE Code | 523489 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | -24.7 |
| Return on Equity | 45.02% |
| Return on Assets | -3.06% |
| 52-Week Range | ₹31.51 – ₹57.48 |
| 1-Year Price Change | -21.3% |
| 3-Month Price Change | -2.4% |
| Beta (1Y) | 0.53 |
| Headquarters | Chennai, Tamil Nadu |
| Website | www.cmmh.in |
| Revenue | ₹9 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 0.0% |
| EPS (Basic) | ₹0.00 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Chennai Meenakshi Multispeciality Hospital Limited operates a multi-specialty hospital in Chennai, India. It also sells pharmacy products. The company was formerly known as Devaki Hospital Limited and changed its name to Chennai Meenakshi Multispeciality Hospital Limited in November 2007. Chennai Meenakshi Multispeciality Hospital Limited was incorporated in 1990 and is based in Chennai, India.
1. Hospital-This segment operates a hospital. It offers services in the areas of cardiology, cosmetic and plastic surgery, diabetology, endocrinology, dermatology, dentistry, ENT, surgical gastroenterology, general surgery, and gynecology.
1. Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Chennai Meenakshi Multispecialit | ₹28 Cr | -24.7 | 45.02% | ₹9 Cr | -21.3% |
Listed by market capitalisation. Ratios are shown for context only.
Chennai Meenakshi Multispecialit is trading at ₹36.40, with a market capitalisation of ₹28 Cr.
Chennai Meenakshi Multispecialit operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Chennai Meenakshi Multispecialit has a P/E of -24.7 and a return on equity of 45.02%.
Chennai Meenakshi Multispecialit is listed on the BSE under the scrip code 523489.
Chennai Meenakshi Multispecialit's share price is down 21.3% over one year and down 2.4% over three months. Its 52-week range is ₹31.51 to ₹57.48.
In Q1 FY27, Chennai Meenakshi Multispecialit reported revenue of ₹9 Cr and net profit of ₹0 Cr, with basic EPS of ₹0 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.